Articles From: PGE to Build Additional Natural Gas Plant at Port Westward to Pharmagen Announces Year-End Financial Results


2013/1/31
Portland General Electric Company (NYSE: POR) today announced its proposed Port Westward Unit 2 flexible generating resource, to be located near Clatskanie, was selected as the successful bid in a capacity request for proposals to help meet customer needs and provide system reliability.
Sign-up for PGE to Build Additional Natural Gas Plant at Port Westward investment picks
2013/3/20
Leader in Telecommunication and Broadband Services in the Nordic and Baltic Countries to Resell PGi's Business Collaboration Solutions, Including iMeet® and GlobalMeet® Audio ATLANTA , March 20, 2013 /PRNewswire/ --  PGi (NYSE: PGI) , a global leader in virtual meetings for over 20 years, today announced a new strategic alliance with TeliaSonera , a leading provider of network access and telecommunication services in the Nordic and Baltic countries, to bring PGi's virtual meeting and cloud-based collaboration solutions to TeliaSonera's business and consumer customers in these regions.
Sign-up for PGi and TeliaSonera Announce New Strategic Alliance investment picks
2013/3/14
Technology Association of Georgia Honors the State's "Best of the Best" for Innovation and Contributions to Georgia's Technology Community ATLANTA , March 14, 2013 /PRNewswire/ -- PGi (NYSE: PGi) today announced that the Technology Association of Georgia (TAG), the state's leading association dedicated to the promotion and economic advancement of Georgia 's technology industry, has chosen PGi  as one of its Top 10 Innovative Technology Companies in Georgia .
Sign-up for PGi Named a TAG Top 10 Innovative Technology Company investment picks
2013/4/18
Company Revises 2013 Financial Outlook to Reflect Recent Changes in Foreign Currency Exchange Rates ATLANTA , April 18, 2013 /PRNewswire/ -- Premiere Global Services, Inc. (NYSE: PGI) , a global leader in virtual meetings for over 20 years, today announced results for the first quarter ended March 31, 2013 .
Sign-up for PGi Reports First Quarter 2013 Results: Revenues $129.5M, Non-GAAP Diluted EPS from Continuing Operations $0.19* investment picks
2013/2/13
Company Sees Solid Organic Growth and Higher Profitability in 2013 ATLANTA , Feb.
Sign-up for PGi Reports Fourth Quarter and Fiscal Year 2012 Results: Q4 Organic Revenues Grew Over 6%* to $125.8M, Non-GAAP Diluted EPS from Continuing Operations $0.18* investment picks
2013/4/4
ATLANTA, April 4, 2013 /PRNewswire/ -- PGi (NYSE: PGI) , a global leader in virtual meetings for over 20 years, today announced that it plans to release results for the first quarter ended March 31, 2013 , after the market close on Thursday, April 18, 2013 .
Sign-up for PGi to Announce First Quarter 2013 Results on Thursday, April 18, 2013 investment picks
2013/1/31
ATLANTA, Jan.
Sign-up for PGi to Announce Fourth Quarter and 2012 Results on Wednesday, February 13, 2013 investment picks
2013/4/3
WARSAW --The supervisory board of Polish natural gas utility PGNiG SA (PGN.WA) has dismissed its recently hired head of exploration and production, Krzysztof Bocian, because he didn't agree to a "standard" non-compete clause in his contract, the company said Wednesday.
Sign-up for PGNiG Dismisses Upstream Chief Before He Takes Office investment picks
2013/3/25
VENICE, Fla., March 25, 2013 (GLOBE NEWSWIRE) -- PGT, Inc. (Nasdaq:PGTI) , the leading U.S. manufacturer and supplier of residential impact-resistant windows and doors, announced that it had filed a shelf registration statement with the U.S. Securities Exchange Commission on Form S-3 pursuant to a notice from JLL Partners Fund IV, LP ("JLL"), the holder of approximately 62% of the Company's outstanding common stock, under a registration rights agreement between JLL and the Company.
Sign-up for PGT Announces Filing of Registration Statement for Possible Sale of Shares by JLL Partners Fund IV, LP investment picks
2013/2/20
VENICE, Fla., Feb.
Sign-up for PGT Reports 2012 Fourth Quarter Results investment picks
2013/5/1
VENICE, Fla., May 1, 2013 (GLOBE NEWSWIRE) -- PGT, Inc. (Nasdaq:PGTI) , the leading U.S. manufacturer and supplier of residential impact-resistant windows and doors, announces financial results for its first quarter ended March 30, 2013.
Sign-up for PGT Reports 2013 First Quarter Results investment picks
2013/4/5
VENICE, Fla., April 5, 2013 (GLOBE NEWSWIRE) -- PGT, Inc. (Nasdaq:PGTI) will host a conference call on Thursday, May 2, 2013, to discuss the company's first quarter results as well as other business matters.
Sign-up for PGT, Inc. Announces 2013 First Quarter Results Conference Call investment picks
2013/4/4
DETROIT , April 4, 2013 /PRNewswire/ -- Amgen Inc. (NASDAQ: AMGN) , Bristol-Myers Squibb Company (NYSE: BMY) , Eli Lilly and Company (NYSE: LLY) , Johnson & Johnson (NYSE: JNJ) , Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE) today joined thirteen institutional investors in endorsing a set of principles aimed at deterring violations of health care laws.
Sign-up for Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures investment picks
2013/3/19
DUBLIN, Ohio , March 19, 2013 /PRNewswire/ -- Cardinal Health announced today that its pharmaceutical distribution contract with Walgreen Co.
Sign-up for Pharmaceutical Distribution Agreement Between Cardinal Health And Walgreens To End August 2013 investment picks
2013/1/31
Pharmaceutical Executive Warren Whitehead Joins Amorfix as Chief Financial Officer Canada NewsWire TSX: AMF TORONTO , Jan.
Sign-up for Pharmaceutical Executive Warren Whitehead Joins Amorfix as Chief Financial Officer investment picks
2013/4/22
HOFFMAN ESTATES, Ill.
Sign-up for Pharmacy Breach At Little Rock, AR Kmart investment picks
2013/4/1
OptumRx , the American Pharmacists Association (APhA) and the American Association of Colleges of Pharmacy (AACP) today announced the winners of the inaugural Pharmacy is Right for Me high school Innovation Challenge.
Sign-up for Pharmacy is Right for Me Student Innovation Challenge Winners Announced investment picks
2013/4/24
SUNNYVALE, Calif.
Sign-up for Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call investment picks
2013/4/11
Pharmacyclics Inc. (PCYC) said the enrollment of a fifth patient in a clinical trial triggered a $50 million milestone payment from Johnson & Johnson (JNJ) unit Janssen Biotech Inc. The Phase III trial studies Pharmacyclics's drug ibrutinib versus chlorambucil in elderly patients with newly diagnosed chronic lymphocytic leukemia and small lymphocyctic lymphoma.
Sign-up for Pharmacyclics Gets Fourth $50 Million Milestone Payment from Janssen investment picks
2013/4/8
Pharmacyclics Inc. (PCYC) said the U.S. Food and Drug Administration granted an additional breakthrough-therapy designation for its investigational oral agent ibrutinib as a monotherapy to treat patients with chronic lymphocytic leukemia or small lymphocytic lymphoma with deletion of the short arm of chromosome 17.
Sign-up for Pharmacyclics Gets New Breakthrough-Therapy Designation for Ibrutinib investment picks
2013/5/1
SUNNYVALE, Calif.
Sign-up for Pharmacyclics Reports First Quarter 2013 Results investment picks
2013/2/14
SUNNYVALE, Calif.
Sign-up for Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012 investment picks
2013/4/11
SUNNYVALE, Calif.
Sign-up for Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study investment picks
2013/3/7
SUNNYVALE, Calif.
Sign-up for Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock investment picks
2013/3/8
SUNNYVALE, Calif.
Sign-up for Pharmacyclics, Inc. Prices Public Offering of Common Stock investment picks
2013/4/1
SILVER SPRING, Md.
Sign-up for Pharmagen Announces Year-End Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: PGE to Build Additional Natural Gas Plant at Port Westward to Pharmagen Announces Year-End Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity